We constructed a novel three-class classification SVM model to accurately predict patient resistance, which may provide a new strategy for the treatment and research of drug-resistant epilepsy and also revealed that the resistance genes PRKCH and S1PR5 may cooperate with other resistance genes through regulation of the cAMP-response element-binding protein (CREB) signaling pathway. This evidence concerns the gene S1PR5 and epilepsy.